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Papillary carcinoma is the most common thyroid malignancy. Many variants of this tumor have 
been described, with different morphological and molecular characteristics. Although most cases 
have excellent prognosis, the relationship between tumor architecture and its biological behavior 
remains controversial.
Objective: To present the experience of a single center on the prevalence of thyroid papillary 
carcinoma variants and their relationship with other histopathological prognostic factors.
Method: Retrospective study of all the cases submitted to thyroidectomy for papillary carcinoma in 
the same institution over 11 years.
Results: We included 517 patients, 81.9% of them were women. The average age was 47.2 years. 
The variants recognized to have higher aggressiveness potential corresponded to 5.6% of the sample. 
We found an association of tumor subtypes with greater lesion diameter, T staging, lymphovascular 
and gland capsule invasion.
Conclusion: A small percentage of papillary carcinoma cases is represented by variants recognized by 
their greater potential for aggression. There are associations between these variants and several other 
histopathological factors already recognized for their prognostic value, which may, by themselves, 
influence the outcome of these cases.
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INTRODUCTION
Papillary carcinoma (PC) is the most common 
thyroid malignancy. Generally, it is an indolent disease 
and it has a good prognosis if completely resected. 
However, some cases usually related to some specific 
clinicopathological parameters may yield worse outcomes. 
The TNM classification is the most used in the risk 
classification of malignant tumors1. Lymph node metastasis 
in the lateral compartment (N1b), massive extrathyroidal 
disease (T4) and distant metastasis (M1) are independent 
factors that have been correlated with poor prognosis in 
these patients2.
Although some studies on the prognostic value 
of some PC variants have already been developed, our 
knowledge about the prevalence and biological behavior 
of these variants is still poor, especially due to sample 
size. In our study, we investigated the prevalence of these 
histological variants by means of a large institutional series, 
comparing clinicopathological characteristics according 
to histological subtype and between groups with variants 
recognized by their greater or lesser aggressiveness 
potential.
METHOD
Patients
The histopathological records of all patients who 
underwent thyroidectomy with final histopathological 
diagnosis of thyroid PC from June 2000 to December 2010 
were reviewed at our institution. All patients underwent 
clinical and ultrasound evaluation preoperatively. Relevant 
cases underwent cytologic evaluation of thyroid nodules 
by Fine Needle Aspiration (FNA). The central or lateral 
compartment neck dissection is not performed electively 
in our institution, being reserved for patients with clinical 
or ultrasound suspicion of lymph node metastases. Many 
cases of PC, cases of poorly differentiated carcinoma, 
tumors with undifferentiated zones, cases without 
description of the size of the largest nodule, PC cases with 
focal insular component, as well as medullary neoplasia 
associated with thyroid PC, were taken off the study.
The following parameters were entered into 
a specific database (Microsoft® Excel 2003 version, 
Microsoft Corporation, Redmond, WA, USA): age, gender, 
concomitant Hashimoto’s thyroiditis, associated lymph 
node dissection, detailed histopathological description with 
information on the tumor variant or tumor differentiation 
pattern, predominant nodule diameter, multifocality, 
extrathyroidal extension, lymph node group compromised 
and T and N staging. We did not evaluate distant 
metastasis, since only the histopathological reports alone 
were reviewed.
Definitions and Pathology
Tumors were classified into each variant or 
differentiation pattern, similar to that of the World 
Health Organization (WHO) classification3 as: Follicular, 
Oncocytic, Clear Cells, Diffuse Sclerosing, Tall Cells, 
Solid, Cribriform, Fasciitis-like, Macrofollicular, and 
Microcarcinoma. There were no cases belonging to 
the macrofollicular and cribriform variants in our 
sample. Besides these, we added the Columnar and the 
Warthin-like differentiation pattern, present in six cases. 
The conventional, usual or typical thyroid PC cases were 
classified as belonging to the Classic pattern or variant. 
When evaluating the microcarcinomas, we ran descriptive 
analysis of tumor differentiation patterns similarly to the 
previously described variants. For statistical purposes, 
we grouped differentiation patterns and tumor variants. 
When more than one variant or differentiation pattern 
were present in the same case, these were considered 
complex variants or tumor patterns. These were described 
as shown on Table 1.
Table 1. Distribution of tumor patterns and variants among 
complex tumors.
TU > 1 cm (N = 29) Tumor variants N
Follicular 20
Classic 16
Solid 15
Oncocytic 8
Tall cells 3
Columnar 2
Clear Cells 1
Diffuse sclerosing 1
TU ≤ 1 cm (N = 7) Differentiation pattern
Follicular 5
Classic 4
Oncocytic 3
Solid 1
TU: Tumor; N: Absolute frequency; %: Relative frequency; cm: Cen-
timeters.
Tumors were considered multifocal when two or 
more foci were found in one or both lobes. Hashimoto’s 
thyroiditis has been suggested based on histopathological 
findings. Papillary microcarcinomas were defined as 
tumors with no more than 1.0 cm in diameter at the 
final histological examination. The Tall, Columnar, Solid 
or Diffuse Sclerosing Cells were defined as variants 
or differentiation patterns with greater aggressiveness 
potential; and those with the less malignancy potential 
were the Classical, Follicular and Oncocytic types. Other 
variants or patterns of tumor differentiation were excluded 
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Table 2. Descriptive analysis of the clinicopathological traits among variants or differentiation patterns carrying a higher malignancy 
potential.
Case Gender Age
Variant or 
differentiation 
pattern
Hashimoto Multifocality
Lymph 
vascular/ 
neural invasion
Largest 
nodule 
diameter
Gland 
capsular 
invasion
Extraglandular 
spill T N
1 F 34 Tall cells A A A 2.6 P A T2 N0
2 F 53
Tall Cells + 
sclerosing 
(< 50%) + follicular 
(< 50%)
A P A 2 P P T3 N0
3 F 56
Tall Cells (< 50%) + 
follicular + oncocytic 
(< 50%)
P P A 2 A A T1 N0
4 F 68 Column A A A 0.5 A A T1 N0
5 F 56
Column 
(< 50%) + solid 
(< 50%) + follicular
A P A 2.5 P A T2 N0
6 F 67
Column + solid 
(< 50%) + follicular 
(< 50%)
P P A 4 P A T2 N0
7 F 61 Sclerosing A A A 7 P A T3 N0
8 F 35 Sclerosing A P A 1.1 P P T3 N1b
9 F 25 Sclerosing A A P 2.5 P P T3 N1b
10 F 39 Sclerosing P P A 3 P P T3 N1b
11 F 68 Sclerosing A A A 1 P P T3 N0
12 F 49 Solid A A A 0.8 A A T1 N0
13 F 77 Solid A P A 1.5 A A T1 N0
14 F 41 Solid A P A 2 P P T3 N1a
15 F 60 Solid A A A 5.5 A A T3 N0
16 M 64
Solid (< 50%) 
+ Tall Cells 
(< 50%) - follicular
A A P 6.5 P A T3 N1b
from the statistical calculation and are only presented 
descriptively.
Complex tumor cases with tumor nodules or zones 
classified in the higher malignancy category were grouped 
with other similar cases for the purpose of statistical 
calculation and are listed on Table 2. The same was true 
among cases with low malignancy potential. Pathological 
staging was performed according to the seventh edition 
of the American Joint Committee on Cancer pTNM staging 
system4. Lymph node status was defined by pathological 
evidence of metastases in the lymph nodes which were 
removed. Extraglandular involvement was defined based 
on evidence of tumor infiltration beyond the capsule 
gland upon microscopic examination. We performed a 
comparative analysis of clinical and histopathological 
variables among the Classic, Follicular and Oncocytic 
variants, and among the groups with variants recognized 
by the highest and lowest potential for aggression, as 
previously agreed. All the data was collected by the same 
researcher (Girardi FM) and the entire pathology review 
was carried out by the same pathologist (Barra MB).
Statistics and Ethical Aspects
Descriptive analysis was used to summarize the 
data. We performed the Kolmogorov-Smirnov test to assess 
normality of continuous variables. Continuous variables 
with normal distribution were expressed as mean and 
standard deviation. Those with abnormal distribution 
were also expressed as median, minimum and maximum 
values. Categorical variables were expressed as absolute 
and relative frequency. We used Student’s t test and 
ANOVA for comparing mean ages; the Mann-Whitney 
U test and Kruskal-Wallis tests were used for comparing 
tumor diameter and the nonparametric chi-square test was 
used to compare categorical variables. Statistical analysis 
was performed using the EpiInfo software, version 3.4.3, 
2007. All tests considered significance level of 5%.
The authors guarantee data keeping and the 
confidentiality of the material obtained. As there were no 
interventions, we did not have to use the Informed Consent 
Form. The project was approved by the Ethics Committee 
of our institution (Project No 3483/11).
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17 M 69 Solid + clear cells (< 50%) A A P 8 P P T3 N1b
18 F 63 Solid + classic (< 50%) P A A 0.4 A A T1 N0
19 F 33 Solid (< 50%) + classic A A A 5 P P T3 N0
20 M 72 Solid (< 50%) + classic A A P 6.4 P P T3 N0
21 F 46 Solid + follicular (< 50%) P P A 1.5 P A T1 N1a
22 F 43 Solid + follicular (< 50%) A A A 3.8 A A T2 N0
23 M 29 Solid + follicular (< 50%) A A A 3.6 P A T2 N0
24 F 23 Solid + follicular (< 50%) A A P 4.5 P P T3 N0
25 F 51
Solid + follicular 
(< 50%) + classic 
(< 50%)
A P A 2 P A T1 N0
26 F 56
Solid (< 50%) + follicular 
+ oncocytic 
(< 50%)
P A A 2.2 P A T2 N1a
27 F 58 Solid + follicular (< 50%) + oncocytic (< 50%) A P A 1.8 P P T3 N0
28 F 38 Solid (< 50%) +oncocytic A A A 1.2 P P T3 N0
29 F 13
Solid (< 50%) 
+ oncocytic (< 50%) + 
classic
A A P 3.1 P P T3 N0
Continuation Table 2.
F: Females; M: Males; Age in years; Diameter in centimeters; A: Absent; P: Present; T: Staging T; N: Staging N.
RESULTS
Between June 2000 and December 2010, there 
were 623 thyroidectomy for thyroid cancer performed in 
our institution. Eight cases were excluded due to lack of 
tumor diameter information, all corresponding to Classic 
PC. Altogether, 517 (82.9%) patients met the inclusion 
criteria. Of the total, 81.9% were women. The male:female 
ratio was 1:4.5. The average age was 47.20 years, range of 
13-87 years. We observed that the Microcarcinoma variant 
was the most prevalent, with 42.1% of cases, followed by 
the Classical and Follicular variants, respectively (Table 3).
In 36 cases there were more than one tumor variant 
or differentiation pattern in the same gland, and the Classic 
variation or differentiation pattern was the most prevalent 
in those cases. Except for nodule size, we did not detect 
statistically significant differences between the Classical, 
Follicular and Oncocytic variants or differentiation pattern 
(Table 4). However, this difference was not maintained 
when we compared the diameter between the Classical 
and Oncocytic variants (p = 0.2842), as well as when 
we compared the Follicular and Oncocytic variants 
(p = 0.2129), only the Classical and Follicular variants, as 
per the Mann-Whitney U test (p = 0.002).
As noted on Tables 2 and 5, those variants 
recognized by having the highest malignancy potential 
accounted for only 5.6% of the sample, and the solid 
variant predominated. We did not observe statistically 
significant differences between age, gender, multifocality, 
Table 3. Descriptive analysis of tumor patterns and variants 
among cases of thyroid papillary carcinoma.
Variants or differentiation patterns N (517) % (100)
Classic variant 164 31.7
Follicular variant 83 16.0
Oncocytic variant 10 1.9
Diffuse sclerosing variant 4 0.7
Warthin-like variant 4 0.7
Solid variant 3 0.5
Tall Cells variant 1 0.1
Fasciite-like variant 1 0.1
Complex tumors 29 5.6
Microcarcinoma variant 218 42.1
Classic pattern 174 ----
Follicular pattern 25 ----
Oncocytic pattern 8 ----
Solid pattern 1 ----
Columnar pattern 1 ----
Sclerosing diffuse pattern 1 ----
Warthin-like pattern 1 ----
Complex tumors 7 ----
N: Absolute frequency; %: Relative frequency.
Hashimoto’s thyroiditis and positive neck lymph nodes 
between groups with lower or higher malignancy potential 
variants or differentiation pattern (Table 5). However, 
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Table 4. Analysis of the clinicopathological characteristics among tumor variants or differentiation patterns (classic x follicular x 
oncocytic).
Variant/differentiation pattern
p-valueClassic Follicular Oncocytic Total
Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Age 46.6 (14.00) 47.75 (13.94) 50.81 (12.99) 47.04 (13.95) 0.3785
Tumor diameter (m ± SD) 1.39 (1.29) 2.27 (1.74) 1.88 (1.61) 1.63 (1.48) ----------
Median (Min-Max) Median (Min-Max) Median (Min-Max) Median (Min-Max)
Tumor diameter 1 (0.01-7.5) 1.6 (0.1-9) 1.3 (0.2-6) 1.2 (0.01-9) 0.0290
N (329) % (70.7) N (118) % (25.3) N (18) % (3.8) N (465) % (100)
Men/Women 56/273 17.0/82.9 24/94 20.3/79.6 4/14 22.2/77.7 84/381 18.0/81.9 0.6490
Associated Hashimoto’s thyroiditis 44 13.3 22 18.6 3 16.6 69 14.8 0.3756
Lymph-vascular/neural invasion 18 5.4 11 9.3 0 0 29 6.2 0.1783
Multifocality 117 35.5 44 37.2 4 22.2 165 35.4 0.4603
Extraglandular spill 96 29.1 30 25.4 6 33.3 132 28.3 0.6610
Gland capsular invasion 177 53.7 60 50.8 8 44.4 245 52.6 0.6656
Positive neck LN 73 22.1 25 21.1 4 22.2 102 21.9 0.9744
LNs involved in the lateral 
compartment 28 8.5 7 5.9 0 0 35 7.5 0.3082
T Stage: 1-2 226 68.6 78 66.1 12 66.6 316 67.9
0.8684
T Stage: 3-4 103 31.3 40 33.8 6 33.3 149 32.0
N: Absolute frequency; %: Relative frequency; SD: Standard deviation; Min-Max: Variation between minimum and maximum; Age in years; 
Diameters in centimeters; The underscored diameter values differ among themselves as per the Mann-Whitney U test (p = 0.002); LNs: Lymph 
nodes. Notice: We excluded 17 cases of complex tumors, six of them with oncocytic zones; p-value: Level of significance utilized.
Table 5. Analysis of the clinicopathological traits according to tumor variants or differentiation pattern (high x low malignant potential).
Variant/differentiation pattern p-value
High malignancy potential Low malignancy potential Total
Mean (SD) Mean (SD) Mean (SD)
Age 49.89 (16.50) 47.04 (13.96) 47.20 (14.11) 0.3685
Tumor diameter 3.03 (2.06) 1.64 (1.48) 1.72 (1.55) ----------
Median (Min-Max) Median (Min-Max) Median (Min-Max)
Tumor diameter 2.5 (0.4-8) 1.2 (0.01-9) 1.2 (0.01-9) 0.0229
N (29) % (5.6) N (482) % (93.9) N (511) % (100)
Men/Women 4/25 13.7/86.2 88/394 18.2/81.7 92/419 18.0/81.9 0.7197
Associated Hashimoto’s thyroiditis 4 12.9 69 14.3 73 14.2 0.8273
Lympho-vascular/neural invasion 6 20.6 30 6.2 36 7.0 0.0098
Multifocality 11 37.9 183 37.9 194 37.9 0.9969
Extraglandular spill 13 44.8 139 28.8 152 29.7 0.1052
Gland capsular invasion 22 75.8 257 53.3 279 54.5 0.0296
Positive neck LNs 8 27.5 107 22.1 115 22.5 0.6558
LNs involved in the lateral 
compartment 5 17.2 36 7.4 41 8.0 0.1261
T Stage: 1-2 13 44.8 325 67.4 338 66.1
0.0217
T Stage: 3-4 16 55.1 157 32.5 173 33.8
N: Absolute frequency; %: Relative frequency; SD: Standard deviation; Min-Max: Variation between minimum and maximum; Age in years; Diameters 
in centimeters; LNs: Lymph nodes. Notice: We excluded 17 cases of Warthin-like and fasciite-like tumors; p-value: Level of significance utilized.
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we observed their association with larger tumor size, 
lymphovascular and gland capsule invasion and T staging.
DISCUSSION
The most prevalent variant or differentiation pattern 
in our study, grouped microcarcinomas, was the Classic, 
followed by the Follicular variant or pattern. Together 
accounted for 86.2 % of the total. Similar percentages have 
been observed in other series5,6; and the study by Lam 
et al.5 was the one that most closely approximated to the 
figures in our sample. Studies have shown that, despite 
some histological differences observed between the Classic 
and Follicular variants of thyroid PC, both neoplasms have 
favorable prognosis and similar cancer-specific survival at 
10 and 15 years7. Lang et al.7 observed fewer metastatic 
lymph nodes and lower extraglandular overflow rate 
among the Follicular variant cases when compared to the 
usual forms of PC. Ozdemir et al.8 showed greater tumor 
diameter, although lower prevalence of capsular invasion 
and extraglandular extravasation among Follicular variant 
cases when compared to the Classic one.
Likewise, although there are differences in the 
literature9, in most cases involving the Oncocytic variant 
of thyroid PC, the tumor is confined to the gland without 
evidence of association with poor prognosis histological 
features10. There are molecular differences between 
Oncocytic Carcinomas and the Oncocytic variant of the 
thyroid PC, suggesting that both diseases have different 
are genetic behavior11. Moreover, under the same staging 
classification, there is no evidence that the thyroid PC 
Oncocytic variant differs from the usual forms and the PC 
Follicular variant in biological behavior and malignancy 
potential6,10.
In our study, except for tumor size, neither 
difference was observed between the clinical and 
pathological parameters involving the variants: Classic, 
Follicular and Oncocytic. In the analysis of subgroups, 
even diameter differences do not sustain, this being a 
different characteristic among the cases of Follicular 
and Classic variants in the sample, similar to the study 
by Ozdemir et al.8. It is known that the follicular variant 
diagnosis of CP in the preoperative period is a challenge, 
both from the cytology point-of-view12 as well as the 
clinical-echographical point of view8, which may have 
delayed the diagnosis of this tumor variant and justify the 
larger diameter this histological subtype in relation to the 
classical form of PCin our sample.
Many different histologic variants have been 
described for the thyroid PC. Some variants have been 
associated with worse prognosis13. Michels et al.14 
developed a study analyzing survival between patients with 
regular thyroid PC and those with the Tall Cells variant. 
The 10-year survival was 90% and 79%, respectively. In an 
univariate analysis, the Tall Cells variant was associated 
with worse outcomes, which was not confirmed in the 
multivariate analysis. Other authors have developed similar 
studies involving other histological subtypes recognized 
by their worst prognosis, and in all of them, the evidence 
that the histological variant is an independent predictor 
with respect to outcome is weak13. The Columnar variant, 
similarly to the Tall Cells variant, shows an association with 
advanced locoregional disease and distant metastases6. 
Falvo et al.15 developed a comparative study of 83 cases 
of Diffuse Sclerosing variant with 183 cases of the usual 
forms. They concluded that the Diffuse Sclerosing variant 
is characterized by intrathyroidal spread and a high rate of 
lymph node and lung metastases. Sywak et al.16 reported 
that the Solid variant has a high propensity to extrathyroidal 
extension and lymph node metastasis. Like the previously 
described studies, we observed association between 
variants or cases with differentiation pattern having 
greater potential for malignancy and various histological 
features historically known for their association with poor 
prognosis.
Despite the representative sample volume of our 
study, cases recognized by worst potential prognosis are 
rare and account for a small part of the total number of 
thyroid PC cases, which makes it difficult to compare the 
clinical and histopathological data between each variant 
separately. Jung et al.17 in an institutional series of 14 years, 
gathered 23 cases of variants with the greatest malignancy 
potential (ten cases of the Tall Cell variant, five Diffuse 
Sclerosing, four Columnar, three of the Solid variant and 
one mixed case between the Columnar and Tall Cell 
variants) for comparative analysis of prognostic factors 
and outcomes in a group of cases of poorly differentiated 
thyroid carcinoma. Similarly, we chose to unify all cases of 
variants historically known for their association with poor 
prognosis in a single comparison group. Little is known 
about the role played by worse prognosis variants’ foci 
or zones in the context of Classic, Follicular or Oncocytic 
variants or patterns. We chose to include them with the 
other cases with the greatest potential for malignancy for 
statistical calculation purposes. All cases that contained 
variants or patterns of differentiation recognized by 
worse prognosis are individually listed on Table 2, with 
discrimination of the predominant subtype, which we 
believe can collaborate in number for subsequent studies 
from other research centers, given the low incidence of 
these tumor variants even in large series.
There is a hypothesis that the thyroid PC has its 
beginnings in the Follicular Classic pattern, and with time 
it transforms into more malignant forms, depending on 
some molecular events, all the way to poorly differentiated 
and anaplastic tumors. Thus, it is postulated that patients 
with more malignant forms should be older, acquiring, 
in the course of the disease, all the histopathological 
characteristics already recognized of poor prognosis18. This 
744
Brazilian Journal of otorhinolaryngology 79 (6) novemBer/DecemBer 2013
http://www.bjorl.org  /  e-mail: revista@aborlccf.org.br
model has been well studied among Tall Cell variants, 
represented in our study by only four cases with ages 
ranging between 34-64 years. In our study, we found no 
statistical correlation of age with tumor variant, which we 
believe may have been influenced by the low representa-
tion of this variant in our sample, besides excluding cases 
with areas of poorly differentiated carcinoma and tumors 
with areas of anaplasia.
CONCLUSION
The Columnar, Tall Cells, Diffuse Sclerosing, Solid 
variants are usually more malignant than the Classical, 
Follicular and Oncocytic variants of the thyroid PC. 
Although prognostic studies using multivariate analysis, 
have publicized that the histologic subtype has lost strength 
as an independent predictor of worse outcomes, the forms 
for higher malignancy potential tend to be associated 
with several other factors historically reported in cases of 
unfavorable outcomes, alerting the physician that he/she is 
facing a potentially malignant tumor. We believe that our 
study came to add to the current knowledge, especially 
as a substrate for further studies involving more than one 
research center, given the low occurrence of some of 
these variants.
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